Press / Media
Search results
-
Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting
11/9/20 → 11/10/20
6 items of Media coverage
Press/Media: Press / Media
-
Vigeo Therapeutics To Present New Phase 1/2 VT1021 Dose Escalation And Expansion Data At The Society For Immunotherapy Of Cancer's 2020 Annual Meeting
11/9/20
2 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual Meeting
5/14/20
17 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual Meeting; Clinical response was associated with tumor-specific replication, PD-L1 upregulation, and CD8+ cell recruitment in multiple my
5/14/20
5 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda in Patients with Advanced Pancreatic Adenocarcinoma
11/7/19
1 item of Media coverage
Press/Media: Press / Media
-
-Oncolytics Biotech Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda in Patients with Advanced Pancreatic Adenocarcinoma
11/7/19
1 item of Media coverage
Press/Media: Press / Media
-
Autophagy Modulation May Be a Novel Approach to Treatment of Advanced Cancers
11/29/15 → 11/6/19
2 items of Media coverage
Press/Media: Press / Media
-
Market Movers: Oncolytics Biotech, Xerox and Office Depot
11/6/19
1 item of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech(R) Announces Publication of Positive REO 024 Study Results for Pelareorep in Combination with Keytruda(R) in Patients with Advanced Pancreatic Adenocarcinoma
11/6/19
11 items of Media coverage
Press/Media: Press / Media
-
Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up
5/28/19
1 item of Media coverage
Press/Media: Press / Media
-
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma; G-202-003
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech(R) Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/19/18 → 1/20/18
18 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/20/18
1 item of Media coverage
Press/Media: Press / Media
-
Poster Presentation At The 2018 Gastrointestinal Cancers Symposium Sponsored By Asco In Patients With Relapsed Metastatic Adenocarcinoma Of The Pancreas
1/19/18
2 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech® Announces Abstract for Poster Presentation at the 2018 Gastrointestinal ...
1/17/18
1 item of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech® Announces Abstract for Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/17/18
1 item of Media coverage
Press/Media: Press / Media
-
Abstract For Poster Presentation At The 2018 Gastrointestinal Cancers Symposium Sponsored By Asco In Patients With Relapsed Metastatic Adenocarcinoma Of The Pancreas
1/16/18
2 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech(R) Announces Abstract for Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/16/18
13 items of Media coverage
Press/Media: Press / Media
-
Oncolytics Biotech Inc. (ONCYF: OTCQX International) | Oncolytics Biotech(R) Announces Abstract for Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/16/18
3 items of Media coverage
Press/Media: Press / Media
-
Oncolytics BiotechR Announces Abstract for Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
1/16/18
1 item of Media coverage
Press/Media: Press / Media